Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Directorate Change

3 Jul 2006 07:00

Embargoed Release: 07:00hrs, 3 July 2006 Nanoscience Inc. (`Nanoscience' or the `Group') Directorate Changes Nanoscience, the specialist nanotechnology investment holding company, ispleased to announce the appointment of Guy Spelman to its Board as ExecutiveDirector with immediate effect. Mr Spelman brings with him a wealth ofexperience having held numerous senior positions at several global companiesincluding Managing Director of the Reuters account for BT Global Services andVice President of IBM Global Services. Mr Spelman will chair the Group'sinvestment committee and will be the principal point of liaison between theGroup and its shareholders. Mr Spelman will also use his experience toimplement an enhanced corporate governance model for the Group as it continuesto source high-growth investment opportunities in leading-edge technologies. Itis the intention of the Board to continue to procure investment opportunitiesthrough its various networks including its exclusive IP option agreement withImperial College.Alongside Mr Spelman, the Group is also pleased to announce the immediateappointment of Philippe Tischhauser as Non-Executive Director. Mr Tischhauserdeveloped his career with a number of the major global accounting firms, asboth an auditor and a corporate advisor, including Ernst & Young where he was asenior partner in the corporate finance department in Geneva before going on tobecome a Board director of Ernst & Young Holding AG. It is the Board's beliefthat as a qualified CPA with extensive corporate finance experience, MrTischhauser will bring to the Group a wider perspective when evaluating futureinvestments. In addition to advising on the structure of future investments, MrTischhauser will also be responsible for assessing the ongoing financialrobustness and performance of the Group's portfolio companies.In addition to the above appointments, Patrick Stephansen has today steppeddown from the main Nanoscience Board but remains with the Group and willoversee the growth of the Group's Taiwanese joint-venture, Future Waves Pte.Richard Rose, Chairman, commented:`It is with great pleasure that we welcome both Guy and Philippe to the mainBoard of Nanoscience. I have no doubt that their combined experience will proveto be of great value to the Group as we continue to seek out and invest ininnovative leading-edge technologies.I would like to thank Patrick for his contribution to the Board and lookforward to reporting on the progress that our joint-venture, Future Waves,makes under his stewardship.'Information regarding Guy SpelmanFull Name: Guy Dennis SpelmanAge: 47Current Directorships/Partnerships Past Directorships/Partnerships Toumaz Technology Limited Play Cricket.com Pelagon Limited Play-Sport New Media Limited Accretive Technology Arthur Andersen Save for the above, there is no further information required to be disclosedunder paragraph (g) of Schedule 2 of the AIM Rules, with respect to theappointment of Guy Spelman.Information regarding Philippe TischhauserFull Name: Philippe Bernard TischhauserAge: 52Current Directorships/Partnerships Past Directorships/Partnerships The Corporate Finance Group None Broch and Associes Save for the above, there is no further information required to be disclosedunder paragraph (g) of Schedule 2 of the AIM Rules, with respect to theappointment of Philippe Tischhauser.Further Information:Richard Rose Nanoscience 07836 250 474 Andrew Tan Hansard Communications 020 7245 1100 ENDNANOSCIENCE INC
Date   Source Headline
14th Jun 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
6th Jun 20195:43 pmRNSHolding(s) in Company
6th Jun 20193:30 pmRNSInvestment in Frontier Smart Technologies Grp Ltd
30th May 20197:00 amRNSFormal Chairman Appointment
29th May 20191:02 pmRNSHolding(s) in Company
29th May 20197:00 amRNSHolding(s) in Company
21st May 20197:00 amRNSHolding(s) in Company
20th May 20199:00 amRNSPrice Monitoring Extension
20th May 20197:00 amRNSTermination of Discussions and Holding in Company
17th May 201912:01 pmRNSHolding(s) in Company
14th May 201912:07 pmRNSResult of Annual General Meeting
9th May 20194:40 pmRNSSecond Price Monitoring Extn
9th May 20194:35 pmRNSPrice Monitoring Extension
9th May 20197:00 amRNSTrading Update
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
20th Mar 20197:00 amRNSFinal Results
7th Mar 20197:00 amRNSBlock listing Interim Review
6th Mar 20197:00 amRNSNotice of Results
28th Feb 20197:00 amRNSFrontier extends focus into Smart Home IoT
17th Jan 20197:00 amRNSTrading Update and Notice of Results
11th Jan 201911:36 amRNSNotification of Major Holdings
30th Nov 20185:19 pmRNSNotification of major holdings
15th Nov 20187:00 amRNSTotal Voting Rights
28th Sep 20183:36 pmRNSBlock Listing Update
18th Sep 20187:00 amRNSHalf-Year Results
16th Aug 20187:00 amRNSTotal Voting Rights
13th Aug 20187:00 amRNSNotice of Results
26th Jul 20187:00 amRNSTrading Update
16th Jul 20187:00 amRNSTotal Voting Rights
9th Jul 20187:00 amRNSBoard Appointment
12th Jun 20184:27 pmRNSTotal Voting Rights
23rd May 201811:05 amRNSSecond Price Monitoring Extn
23rd May 201811:00 amRNSPrice Monitoring Extension
23rd May 20187:00 amRNSTrading Update
8th May 20185:49 pmRNSTotal Voting Rights
24th Apr 201811:58 amRNSResult of Annual General Meeting
29th Mar 20187:00 amRNSBlock Listing Update and TVR
19th Mar 20184:10 pmRNSPosting of Annual Report and Notice of AGM
8th Mar 20187:00 amRNSBoard Changes
8th Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSNotice of Results
5th Feb 20182:21 pmRNSNotification of major holdings
25th Jan 20187:00 amRNSTrading Update
2nd Jan 20187:00 amRNSNotification of Major Holdings
29th Nov 201712:40 pmRNSDirector/PDMR Shareholding
29th Nov 201712:40 pmRNSTotal Voting Rights
13th Nov 20177:00 amRNSSmart Audio technology contract win
6th Oct 201712:58 pmRNSTotal Voting Rights
28th Sep 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.